Combination chemotherapy
Drug timelines are a Plus or Pro feature.
21 regulatory and trial events tracked for Combination chemotherapy, covering 2013-06-20 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma [Phase 2]